» Articles » PMID: 26743699

Systematic Review of the Literature on Viral Persistence and Sexual Transmission from Recovered Ebola Survivors: Evidence and Recommendations

Overview
Journal BMJ Open
Specialty General Medicine
Date 2016 Jan 9
PMID 26743699
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The main aim of this article is to present a comprehensive, systematic review on evidence of sexual transmission from Ebola survivors and persistence of Ebola virus in body fluids of relevance to sexual transmission, and additionally to review condom effectiveness against sexual transmission of Ebola.

Design: We performed a systematic review of viral persistence in body fluids of relevance to sexual transmission of Ebola survivors and evidence of sexual transmission of Ebola, and carried out a targeted review of condom effectiveness.

Results: We identified nine published original articles presenting results on persistence of Ebola virus in relevant body fluids, or reporting suspect sexual transmission from Ebola survivors. We also included unpublished reports from the current 2014/2015 Ebola epidemic in West Africa. We found no articles reporting on condom effectiveness, but have included a targeted review on general condom efficacy and effectiveness.

Conclusions: We conclude that the risk of sexual transmission from people who have recovered from Ebola cannot be ruled out. We found the longest duration of persistent Ebola RNA in a relevant body fluid from a survivor, to be reported from a man in Sierra Leone who had reverse transcriptase PCR (RT-PCR) positive semen 284 days after symptom onset. In line with current WHO recommendations. We recommend that men are offered the possibility to test their semen regularly for presence of Ebola RNA from 3 months post-symptom onset. Safe sex practices including sexual abstinence, or else condom use, are recommended by WHO until semen has tested negative twice, or in absence of testing for at least 6 months post-symptom onset. Based on evidence reviewed, we conclude that male and female latex condoms offer some protection against EBOV compared to no condom use. Survivors should be offered access to care and prevention, in order to provide them with possibilities to mitigate any risks that may occur, and efforts should be linked to destigmatising activities.

Citing Articles

Beyond COVID-19, the case for collecting, analysing and using sex-disaggregated data and gendered data to inform outbreak response: a scoping review.

Gales M, Yonally Phillips E, Zilversmit Pao L, Dubray C, Rodriguez Ribas Elizalde C, Heidari S BMJ Glob Health. 2025; 10(1).

PMID: 39828430 PMC: 11749539. DOI: 10.1136/bmjgh-2024-015900.


Efficacy of Polyphenylene Carboxymethylene (PPCM) Gel at Protecting Type I Interferon Receptors Knockout Mice from Intravaginal Ebola Virus Challenge.

Escaffre O, Juelich T, Smith J, Zhang L, Pearson M, Bourne N Viruses. 2024; 16(11).

PMID: 39599808 PMC: 11598907. DOI: 10.3390/v16111693.


Features that matter: Evolutionary signatures can predict viral transmission routes.

Wardeh M, Pilgrim J, Hui M, Kotsiri A, Baylis M, Blagrove M PLoS Pathog. 2024; 20(10):e1012629.

PMID: 39432551 PMC: 11527288. DOI: 10.1371/journal.ppat.1012629.


The Susceptibility of BALB/c Mice to a Mouse-Adapted Ebola Virus Intravaginal Infection.

Escaffre O, Juelich T, Smith J, Zhang L, Bourne N, Freiberg A Viruses. 2023; 15(7).

PMID: 37515275 PMC: 10386242. DOI: 10.3390/v15071590.


A comprehensive insight on the challenges for COVID-19 vaccine: A lesson learnt from other viral vaccines.

Soloman Singh R, Singh A, Masih G, Batra G, Sharma A, Joshi R Heliyon. 2023; 9(6):e16813.

PMID: 37303517 PMC: 10245239. DOI: 10.1016/j.heliyon.2023.e16813.


References
1.
Weller S, Davis K . Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev. 2002; (1):CD003255. DOI: 10.1002/14651858.CD003255. View

2.
Renzi C, Tabet S, Stucky J, Eaton N, Coletti A, Surawicz C . Safety and acceptability of the Reality condom for anal sex among men who have sex with men. AIDS. 2003; 17(5):727-31. DOI: 10.1097/00002030-200303280-00011. View

3.
Sagripanti J, Rom A, Holland L . Persistence in darkness of virulent alphaviruses, Ebola virus, and Lassa virus deposited on solid surfaces. Arch Virol. 2010; 155(12):2035-9. DOI: 10.1007/s00705-010-0791-0. View

4.
Saijo M, Niikura M, Ikegami T, Kurane I, Kurata T, Morikawa S . Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins. Clin Vaccine Immunol. 2006; 13(4):444-51. PMC: 1459631. DOI: 10.1128/CVI.13.4.444-451.2006. View

5.
Piercy T, Smither S, Steward J, Eastaugh L, Lever M . The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol. 2010; 109(5):1531-9. DOI: 10.1111/j.1365-2672.2010.04778.x. View